Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
Ting‐Wan Kao, Geng-Hao Bai, Tian‐Li Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 42

Showing 26-50 of 42 citing articles:

Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation
Jingxing Yang, Yu-Chen Chuang, Jen‐Chih Tseng, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Ultrasound -Induced Thermal Effect Enhances the Efficacy of Chemotherapy and Immunotherapy in Tumor Treatment
Yuting Xiang, Li Tang, Hua Pang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6677-6692
Open Access | Times Cited: 1
Spatial resolution of the head and neck cancer tumor microenvironment to identify tumor and stromal features associated with therapy response
Naomi Berrell, James Monkman, Meg L Donovan, et al.
Immunology and Cell Biology (2024) Vol. 102, Iss. 9, pp. 830-846
Open Access | Times Cited: 1
Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
Neeraj Agarwal, James Brugarolas, Pooja Ghatalia, et al.
Annals of Oncology (2024) Vol. 35, Iss. 12, pp. 1148-1156
Closed Access | Times Cited: 1
Spatial transcriptomics in breast cancer reveals tumour microenvironment-driven drug responses and clonal therapeutic heterogeneity
María José Jiménez‐Santos, Santiago García‐Martín, Marcos Rubio‐Fernández, et al.
NAR Cancer (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 1
Spatial Transcriptomics in Breast Cancer Reveals Tumour Microenvironment-Driven Drug Responses and Clonal Therapeutic Heterogeneity
María José Jiménez‐Santos, Santiago García‐Martín, Marcos Rubio‐Fernández, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Illuminating new possibilities: Effects of copper oxide nanoparticles on gastrointestinal adenocarcinoma cells in hypoxic condition
Seyedehsaba Talebian, Bahar Shahnavaz, Mohammadhosein Shakiba, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31414-e31414
Open Access
Energy Metabolism Pathways in Stem Cell Fate Regulation
Mingyue Wang, Xiaoguang Yang, Hongguo Cao
(2024)
Open Access
Insights into miRNA-based therapeutic strategies for oral cancer: Targeting HIF-1α to enhance patient outcomes
Geetha Shanmugam
Oral Oncology Reports (2024) Vol. 11, pp. 100551-100551
Open Access
Pharmacological Regulation Possibilities of HIF for Its’ Mediated Pathologies in Clinical Practice
В. Е. Новиков, О. С. Левченкова
Annals of the Russian academy of medical sciences (2024) Vol. 79, Iss. 3, pp. 261-270
Closed Access
Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis
Sashikanta Swain, Ravi Kant Narayan, P Mishra
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Role of flavonoids in inhibiting triple-negative breast cancer
Shuai Wang, Kuanyu Wang, Cheng Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Exploring The Prognostic and Therapeutic Value of HIF1A in Lung Adenocarcinoma
Zhimin Lu, Yanyu Bi, Jialu Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37739-e37739
Open Access
Comparative Analysis and Future Prospects of Human Epidermal Growth Factor Receptor 2 (HER2) and Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted Antibody-Drug Conjugates in Breast Cancer Treatment
Xiaojuan Gao, Tiansheng Bu, Wenying Wang, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 621-630
Open Access
FGF21 affects the glycolysis process via mTOR-HIF1α axis in hepatocellular carcinoma
Walizeb Khan, Ahmad Zeb, Muhammad Faraz Arshad Malik, et al.
Cellular Signalling (2024), pp. 111522-111522
Closed Access
Myriad factors and pathways influencing tumor radiotherapy resistance
Lanjuan Mi, Hongquan Zhang
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access
Targeting hypoxia and angiogenesis in hepatocellular carcinoma: New insights and therapeutic strategies
Jia-Yi Du, Zhang Chu-ting, Ting Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 12, pp. 1371-1376
Closed Access
The Physiological Functions and Therapeutic Potential of Hypoxia-Inducible Factor-1α in Vascular Calcification
Zhenghong Zhang, Defan Wang, Renfeng Xu, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1592-1592
Open Access
Hypoxia, Stem Cells and Cancer Stem Cells
Mostafa Manian, Marjan Taherian, Hamid Nickho, et al.
Stem cell biology and regenerative medicine (2024), pp. 29-114
Closed Access
Previous Page - Page 2

Scroll to top